• AAPL 165
  • TSLA 147.05
  • AMZN 174.63
  • MSFT 399.12
  • INTC 34.2
  • EURUSD 1.0661
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. CLVLF.PINK

Clinuvel Pharmaceuticals Ltd (CLVLF PINK) stock market data APIs

$9.51 0(0%) as of April 19, 2024

Clinuvel Pharmaceuticals Ltd Financial Data Overview

9.51
9.51
-
9.51
9.51
8.57-13.245
477 M
25.7027
50 127 K
81 757 K
0.1338
0.0034
0.744
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'CLVLF',
Type: 'Common Stock',
Name: 'Clinuvel Pharmaceuticals Ltd',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000D8Y6X0',
ISIN: 'AU000000CUV3',
CUSIP: NULL,
CIK: '1290877',
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Clinuvel Pharmaceuticals Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 81 757 K
  • EBITDA 44 362 K
  • Earnings Per Share 0.37
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Clinuvel Pharmaceuticals Ltd Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast 0

Get Clinuvel Pharmaceuticals Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Clinuvel Pharmaceuticals Ltd latest news via APIs

Clinuvel Pharmaceuticals Limited's (ASX:CUV) largest shareholders are retail investors with 59% ownership, institutions own 20%

Key Insights Clinuvel Pharmaceuticals' significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public 39% of the business is held by the ...

Declining Stock and Solid Fundamentals: Is The Market Wrong About Clinuvel Pharmaceuticals Limited (ASX:CUV)?

Clinuvel Pharmaceuticals (ASX:CUV) has had a rough three months with its share price down 16%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals us...
Do you have any questions?
support@eodhistoricaldata.com